These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 2832322

  • 1. Analysis of the immunomodulatory properties of the secretin-glucagon family of peptides on mouse lymphoid cell functions and the demonstration of specific receptors on T cells.
    Nguyen TT, Krco CJ, Gores A, Go VL.
    Immunol Invest; 1987 Nov; 16(7):555-77. PubMed ID: 2832322
    [Abstract] [Full Text] [Related]

  • 2. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
    Robberecht P, Coy DH, De Neef P, Camus JC, Cauvin A, Waelbroeck M, Christophe J.
    Eur J Biochem; 1987 Jun 01; 165(2):243-9. PubMed ID: 3036504
    [Abstract] [Full Text] [Related]

  • 3. Expression of functional receptors for vasoactive intestinal peptide in freshly isolated and cultured gastric muscle cells.
    Chijiiwa Y, Murthy KS, Grider JR, Makhlouf GM.
    Regul Pept; 1993 Sep 22; 47(3):223-32. PubMed ID: 8234906
    [Abstract] [Full Text] [Related]

  • 4. Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68.
    Van Valen F, Jürgens H, Winkelmann W, Keck E.
    Cell Signal; 1989 Sep 22; 1(5):435-46. PubMed ID: 2561912
    [Abstract] [Full Text] [Related]

  • 5. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Gen Comp Endocrinol; 2004 Jun 22; 137(2):187-95. PubMed ID: 15158130
    [Abstract] [Full Text] [Related]

  • 6. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
    Le Meuth V, Farjaudon N, Bawab W, Chastre E, Rosselin G, Guilloteau P, Gespach C.
    Am J Physiol; 1991 Feb 22; 260(2 Pt 1):G265-74. PubMed ID: 1847591
    [Abstract] [Full Text] [Related]

  • 7. VIP receptor subtypes in mouse cerebral cortex: evidence for a differential localization in astrocytes, microvessels and synaptosomal membranes.
    Martin JL, Feinstein DL, Yu N, Sorg O, Rossier C, Magistretti PJ.
    Brain Res; 1992 Jul 31; 587(1):1-12. PubMed ID: 1326373
    [Abstract] [Full Text] [Related]

  • 8. Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity binding protein for VIP, shown to be identical to calmodulin.
    Andersson M, Carlquist M, Maletti M, Marie JC.
    FEBS Lett; 1993 Feb 22; 318(1):35-40. PubMed ID: 8382169
    [Abstract] [Full Text] [Related]

  • 9. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
    Zhou ZC, Gardner JD, Jensen RT.
    Am J Physiol; 1989 Feb 22; 256(2 Pt 1):G283-90. PubMed ID: 2465694
    [Abstract] [Full Text] [Related]

  • 10. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C, Bawab W, de Cremoux P, Calvo F.
    Cancer Res; 1988 Sep 15; 48(18):5079-83. PubMed ID: 2842044
    [Abstract] [Full Text] [Related]

  • 11. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
    Couvineau A, Rousset M, Laburthe M.
    Biochem J; 1985 Oct 01; 231(1):139-43. PubMed ID: 2998337
    [Abstract] [Full Text] [Related]

  • 12. Dual effect of vasoactive intestinal peptide on the mitogenic response of rabbit spleen lymphocytes.
    Peuriere S, Susini C, Esteve JP, Vaysse N, Escoula L.
    Regul Pept; 1990 Jan 01; 27(1):117-26. PubMed ID: 2155441
    [Abstract] [Full Text] [Related]

  • 13. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
    Sakakibara H, Shima K, Said SI.
    Am J Physiol; 1994 Sep 01; 267(3 Pt 1):L256-62. PubMed ID: 7943252
    [Abstract] [Full Text] [Related]

  • 14. Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages.
    Segura JJ, Guerrero JM, Goberna R, Calvo JR.
    Regul Pept; 1991 Apr 25; 33(2):133-43. PubMed ID: 1652777
    [Abstract] [Full Text] [Related]

  • 15. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
    Christophe J, Waelbroeck M, Chatelain P, Robberecht P.
    Peptides; 1984 Apr 25; 5(2):341-53. PubMed ID: 6089134
    [Abstract] [Full Text] [Related]

  • 16. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB, Dejda A, Niewiadomski P, Gozes I, Nowak JZ.
    J Mol Neurosci; 2005 Apr 25; 25(3):215-24. PubMed ID: 15800375
    [Abstract] [Full Text] [Related]

  • 17. Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses.
    Ottaway CA, Greenberg GR.
    J Immunol; 1984 Jan 25; 132(1):417-23. PubMed ID: 6606671
    [Abstract] [Full Text] [Related]

  • 18. Characterization of VIP-and helodermin-preferring receptors on rat platelets.
    Shima K, Sakakibara H, Said SI.
    Regul Pept; 1996 Jul 05; 63(2-3):99-103. PubMed ID: 8837217
    [Abstract] [Full Text] [Related]

  • 19. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 1. Molecular characterization of the binding site.
    Luis J, Martin JM, el Battari A, Reynier M, Marvaldi J, Pichon J.
    Eur J Biochem; 1989 Mar 15; 180(2):429-33. PubMed ID: 2538330
    [Abstract] [Full Text] [Related]

  • 20. Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes.
    Wanke IE, Rorstad OP.
    Endocrinology; 1990 Apr 15; 126(4):1981-8. PubMed ID: 2156675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.